Case finding and screening strategies for thyroid dysfunction

Clinica Chimica Acta

Volumn 315, Issue 1-2, 2002, Pages 111-124

  Stockigt, Jim R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Hyperthyroidism; Hypothyroidism; Screening tests; Thyroid stimulating hormone

Indexed keywords

ANTITHYROID AGENT; LIOTHYRONINE; LIPID; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ATHEROSCLEROSIS; CASE FINDING; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEART FUNCTION; HEART INFARCTION; HUMAN; HYPOTHYROIDISM; NEUROPSYCHIATRY; OSTEOPOROSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCREENING TEST; SIDE EFFECT; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

CASE-CONTROL STUDIES; CHOLESTEROL; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROTROPIN; THYROXINE;

EID: 0036132962     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00715-X     Document Type: Review

References (80)

1. Screening for thyroid disease
2. Screening for thyroid disease: An update
3. Screening for thyroid disease
4. Population screening for autoimmune thyroid disease
5. Screening for mild thyroid failure at the periodic health examination
6. American Thyroid Association guidelines for detection of TD
7. Congenital hypothyroidism: Etiologies, diagnosis, and management
8. Neonatal screening for congenital hypothyroidism: Results and perspectives
9. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
10. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor developments in infancy
11. Maternal thyroid deficiency and pregnancy complications: Implications for population screening
12. Quantitative assessment of pituitary resistance to thyroid hormone from plots of the logarithm of thyrotropin versus serum free thyroxine index
13. The spectrum of thyroid disease in a community: The Whickham survey
14. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey
15. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom
16. The Colorado thyroid disease prevalence study
17. Thyroid dysfunction in ambulatory elderly Chinese subjects in an area of borderline iodine intake
18. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake
19. A long-term follow-up of postpartum thyroiditis
20. Postpartum thyroid dysfunction: Clinical assessment and relationship to psychiatric affective morbidity
21. Therapeutic controversy. Screening for postpartum thyroiditis
22. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit
23. Thyroid disease in middle-aged and elderly Swedish women; thyroid-related hormones, TD and goitre in relation to age and smoking
24. Observer variation in the clinical and laboratory evaluation of patients with TD and goiter
25. Thyroid function tests - Time for a reassessment
26. Serum TSH and thyroid hormone measurements and assessment of thyroid hormone transport
27. Thyroid stimulating hormone outside the normal range has important implications
28. Accurate diagnosis depends on both clinical judgement and results of tests
29. From guidelines to hospital practice: Reducing inappropriate ordering of thyroid hormone and antibody tests
30. The reduction of the mortality rate in hyperthyroidism
31. Management of the myxedematous patients with symptoms of cardiovascular disease
32. Cardiovascular and atherogenic aspects of subclinical hypothyroidism
33. Thyroid hormone and the cardiovascular system
34. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons
35. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
36. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine
37. Impaired cardiac reserve and exercise capacity in patients receiving long term thyrotropin suppressive therapy with levothyroxine
38. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism
39. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly
40. Hyperthyroidism, thyroid hormone therapy, and bone
41. Low thyrotropin levels are not associated with bone loss in older women: A prospective study
42. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine
43. Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis
44. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study
45. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values
46. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism
47. Metabolic changes in hypothyroidism
48. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature
49. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues
50. Low-density lipoprotein cholesterol in subclinical hypothyroidism
51. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia
52. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects
53. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment
54. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein(a)
55. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a)
56. Elevated serum lipoprotein(a) in subclinical hypothyroidism
57. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)
58. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo
59. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene
60. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes
61. Subclinical hypothyroidism: A modifiable risk factor for depression?
62. Subclinical hypothyroidism: Neurobehavioral features and beneficial effect of L-thyroxine treatment
63. Guidelines for diagnosis and monitoring of thyroid disease: Nonthyroidal illness
64. Drugs and thyroid function
65. Fasting decreases thyrotropin responsiveness to thyrotropin-releasing hormone: A potential cause of misinterpretation of thyroid function tests in the critically ill
66. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness
67. Free thyroid hormone measurement: A critical appraisal
68. Review: Thyroid function in psychiatric illness
69. Thyroid disease and mental illness: A study of thyroid disease in psychiatric admissions
70. Antithyroid peroxidase autoantibodies in thyroid diseases
71. Hypothyroidism: Screening and subclinical disease
72. The clinical spectrum of postpartum thyroid disease
73. The course of thyroid abnormalities during lithium treatment - A 2 year follow-up study
74. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism
75. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a
76. Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-β therapy for multiple sclerosis
77. Are autoimmune thyroid dysfunction and depression related?
78. L-Thyroxine therapy in subclinical hypothyroidism
79. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism
80. Labelling in hypertension: A review of the behavioural and psychological consequences